How COVID-19 might increase risk of memory loss and cognitive decline

by Natalie C. Tronson,The ConversationCredit: CC0 Public DomainOf all frightening ways that the SARS-COV-2 virus affects the body, one of the more insidious is the effect of COVID-19 on the brai

Neurology March 30,2024

How COVID-19 might increase risk of memory loss and cognitive decline

by Natalie C. Tronson,The ConversationCredit: CC0 Public DomainOf all frightening ways that the SARS-COV-2 virus affects the body, one of the more insidious is the effect of COVID-19 on the brai

Neurology March 30,2024

FDA warns 17 companies about illegal Alzheimer disease products

(HealthDay)—A number of warning/advisory letters have been issued to 17 companies for selling illegal products that claim to prevent, treat, or cure Alzheimer disease and other serious conditions, the

Neurology March 30,2024

FDA warns 17 companies about illegal Alzheimer disease products

(HealthDay)—A number of warning/advisory letters have been issued to 17 companies for selling illegal products that claim to prevent, treat, or cure Alzheimer disease and other serious conditions, the

Neurology March 30,2024

Flotillin is a novel diagnostic blood marker of Alzheimer's disease

by Nagoya City UniversityFlotillin in serum collected from patients with AD and non-AD cases was examined by western blot analysis. Intensity of flotillin bands was quantified using Image J. A, The re

Neurology March 30,2024

Flotillin is a novel diagnostic blood marker of Alzheimer's disease

by Nagoya City UniversityFlotillin in serum collected from patients with AD and non-AD cases was examined by western blot analysis. Intensity of flotillin bands was quantified using Image J. A, The re

Neurology March 30,2024

IL-33 ameliorates Alzheimer's-like pathology and cognitive decline

by Hong Kong University of Science and TechnologyIL-33 in Alzheimer's disease. Credit: Division of Life Science, HKUSTAlzheimer's disease (AD) is a devastating condition with no known effectiv

Neurology March 30,2024

IL-33 ameliorates Alzheimer's-like pathology and cognitive decline

by Hong Kong University of Science and TechnologyIL-33 in Alzheimer's disease. Credit: Division of Life Science, HKUSTAlzheimer's disease (AD) is a devastating condition with no known effectiv

Neurology March 30,2024

LipiDiDiet finds broadly sustainable effects of nutrient intervention in early Alzheimer's

by Saarland UniversityCredit: CC0 Public DomainTrial participants who received a multinutrient formulation over an extended period of time showed a significantly less rapid deterioration in cogni

Neurology March 30,2024

LipiDiDiet finds broadly sustainable effects of nutrient intervention in early Alzheimer's

by Saarland UniversityCredit: CC0 Public DomainTrial participants who received a multinutrient formulation over an extended period of time showed a significantly less rapid deterioration in cogni

Neurology March 30,2024

MAO is a possible Alzheimer's disease biomarker

by American Chemical SocietyResearchers used mice studies to reveal that MAO activity (yellow) is directly correlated with the progression of Alzheimer's disease and may be used to stage the

Neurology March 30,2024

MAO is a possible Alzheimer's disease biomarker

by American Chemical SocietyResearchers used mice studies to reveal that MAO activity (yellow) is directly correlated with the progression of Alzheimer's disease and may be used to stage the

Neurology March 30,2024

FDA head calls for inquiry into Alzheimer's drug review

by Matthew PerroneThis image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Friday, July 9, 2021, the acting head of the U.S. Food and Drug Administrati

Neurology March 30,2024

FDA head calls for inquiry into Alzheimer's drug review

by Matthew PerroneThis image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Friday, July 9, 2021, the acting head of the U.S. Food and Drug Administrati

Neurology March 30,2024

Klotho-VS heterozygosity genotype linked to reduced alzheimer disease risk

(HealthDay)—Klotho-VS heterozygosity (KL-VSHET+status) is associated with a reduced risk for Alzheimer disease (AD) and β-amyloid (Aβ) burden in cognitively normal individuals aged older than 60

Neurology March 30,2024

Klotho-VS heterozygosity genotype linked to reduced alzheimer disease risk

(HealthDay)—Klotho-VS heterozygosity (KL-VSHET+status) is associated with a reduced risk for Alzheimer disease (AD) and β-amyloid (Aβ) burden in cognitively normal individuals aged older than 60

Neurology March 30,2024

GPS trackers can save the lives of people with dementia

by University of SouthamptonGPS trackers can save the lives of people with dementia. Credit: University of SouthamptonPeople with dementia should have access to location finding devices – like GP

Neurology March 30,2024

GPS trackers can save the lives of people with dementia

by University of SouthamptonGPS trackers can save the lives of people with dementia. Credit: University of SouthamptonPeople with dementia should have access to location finding devices – like GP

Neurology March 30,2024

FDA advisory panelist outlines issues with aducanumab's approval for Alzheimer's disease

by American College of PhysiciansPET scan of a human brain with Alzheimer's disease. Credit: public domainDespite near unanimous objection from its advisory panel, the U.S. Food and Drug Admi

Neurology March 30,2024

FDA advisory panelist outlines issues with aducanumab's approval for Alzheimer's disease

by American College of PhysiciansPET scan of a human brain with Alzheimer's disease. Credit: public domainDespite near unanimous objection from its advisory panel, the U.S. Food and Drug Admi

Neurology March 30,2024